MSB 1.01% 98.0¢ mesoblast limited

Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients, page-68

  1. 173 Posts.
    lightbulb Created with Sketch. 405

    WOW! Congratulate the Prof and board on this wonderful achievement and the moment we all have been waiting for!

    I always believe that the Prof and our Chair are the best in the business if not the greatest and they just do everything they humanly could for the benefits of all...


    Now We not only can have all the trials but an investigational new drug to treat patients who desperately need!

    DYOR!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
-0.010(1.01%)
Mkt cap ! $1.118B
Open High Low Value Volume
99.5¢ $1.02 97.0¢ $2.821M 2.832M

Buyers (Bids)

No. Vol. Price($)
1 20688 97.5¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 35000 3
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.